Skip to main content
Clinical Trials/ITMCTR2024000094
ITMCTR2024000094Not yet recruitingPhase 1

Study on the mechanism of Jiawei Bushen Zhuangjin Decoction in treating knee osteoarthritis based on transcriptomics

Henan University of Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
50 to 70 (—)
Sex
All

Inclusion Criteria

  • 1) Patients who meet the diagnostic criteria for KOA (unilateral or bilateral);
  • 2) Patients aged between 50 and 70 years old, both male and female;
  • 3) The X-ray K-L grade of the knee joint belongs to grade II-III;
  • 4) KOA stage belongs to the early and middle stages;
  • 5) Patients with good basic conditions, suitable for drug treatment, and no obvious indications of surgery;
  • 6) The patient had good compliance and signed the informed consent.

Exclusion Criteria

  • 1) Have taken traditional Chinese medicine decoction, proprietary Chinese medicine or other Western medicine with KOA treatment in the past week;
  • 2) Participants in other research projects before enrollment;
  • 3) Patients with knee joint tumor, tuberculosis, rheumatism, rheumatoid arthritis, gouty arthritis and other diseases;
  • 4) Patients who have undergone knee replacement;
  • 5) Pregnant or planning to become pregnant or lactating women;
  • 6) Patients with severe primary diseases of the heart, cerebrovascular and hematopoietic systems, mental diseases, malignant tumors, and liver and kidney dysfunction;
  • 7) Participants in other clinical trials that affect the evaluation of the results of this study.

Investigators

Sponsor
Henan University of Chinese Medicine

Similar Trials